BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31769880)

  • 1. Transaldolase haploinsufficiency in subjects with acetaminophen-induced liver failure.
    Oaks Z; Jimah J; Grossman CC; Beckford M; Kelly R; Banerjee S; Niland B; Miklossy G; Kuloglu Z; Kansu A; Lee W; Szonyi L; Banki K; Perl A
    J Inherit Metab Dis; 2020 May; 43(3):496-506. PubMed ID: 31769880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine.
    Hanczko R; Fernandez DR; Doherty E; Qian Y; Vas G; Niland B; Telarico T; Garba A; Banerjee S; Middleton FA; Barrett D; Barcza M; Banki K; Landas SK; Perl A
    J Clin Invest; 2009 Jun; 119(6):1546-57. PubMed ID: 19436114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase.
    Perl A; Hanczko R; Telarico T; Oaks Z; Landas S
    Trends Mol Med; 2011 Jul; 17(7):395-403. PubMed ID: 21376665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of transaldolase deficiency.
    Perl A
    IUBMB Life; 2007 Jun; 59(6):365-73. PubMed ID: 17613166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transaldolase deficiency influences the pentose phosphate pathway, mitochondrial homoeostasis and apoptosis signal processing.
    Qian Y; Banerjee S; Grossman CE; Amidon W; Nagy G; Barcza M; Niland B; Karp DR; Middleton FA; Banki K; Perl A
    Biochem J; 2008 Oct; 415(1):123-34. PubMed ID: 18498245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untargeted metabolomics as an unbiased approach to the diagnosis of inborn errors of metabolism of the non-oxidative branch of the pentose phosphate pathway.
    Shayota BJ; Donti TR; Xiao J; Gijavanekar C; Kennedy AD; Hubert L; Rodan L; Vanderpluym C; Nowak C; Bjornsson HT; Ganetzky R; Berry GT; Pappan KL; Sutton VR; Sun Q; Elsea SH
    Mol Genet Metab; 2020; 131(1-2):147-154. PubMed ID: 32828637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis.
    Oaks Z; Patel A; Huang N; Choudhary G; Winans T; Faludi T; Krakko D; Duarte M; Lewis J; Beckford M; Blair S; Kelly R; Landas SK; Middleton FA; Asara JM; Chung SK; Fernandez DR; Banki K; Perl A
    Nat Metab; 2023 Jan; 5(1):41-60. PubMed ID: 36658399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency.
    Winans T; Oaks Z; Choudhary G; Patel A; Huang N; Faludi T; Krakko D; Nolan J; Lewis J; Blair S; Lai Z; Landas SK; Middleton F; Asara JM; Chung SK; Wyman B; Azadi P; Banki K; Perl A
    J Autoimmun; 2023 Nov; 140():103112. PubMed ID: 37742509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transaldolase: from biochemistry to human disease.
    Samland AK; Sprenger GA
    Int J Biochem Cell Biol; 2009 Jul; 41(7):1482-94. PubMed ID: 19401148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of Ser-171 causes inactivation, proteasome-mediated degradation and complete deficiency of human transaldolase.
    Grossman CE; Niland B; Stancato C; Verhoeven NM; Van Der Knaap MS; Jakobs C; Brown LM; Vajda S; Banki K; Perl A
    Biochem J; 2004 Sep; 382(Pt 2):725-31. PubMed ID: 15115436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of transaldolase deficiency in urine samples by capillary LC-MS/MS.
    Vas G; Conkrite K; Amidon W; Qian Y; Bánki K; Perl A
    J Mass Spectrom; 2006 Apr; 41(4):463-9. PubMed ID: 16470722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent Acetaminophen Toxicity in a Patient with Transaldolase Deficiency.
    Lee-Barber J; English TE; Britton JF; Sobreira N; Goldstein J; Valle D; Bjornsson HT
    JIMD Rep; 2019; 44():9-15. PubMed ID: 29923087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transaldolase deficiency: liver cirrhosis associated with a new inborn error in the pentose phosphate pathway.
    Verhoeven NM; Huck JH; Roos B; Struys EA; Salomons GS; Douwes AC; van der Knaap MS; Jakobs C
    Am J Hum Genet; 2001 May; 68(5):1086-92. PubMed ID: 11283793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular ordering in HIV-induced apoptosis. Oxidative stress, activation of caspases, and cell survival are regulated by transaldolase.
    Banki K; Hutter E; Gonchoroff NJ; Perl A
    J Biol Chem; 1998 May; 273(19):11944-53. PubMed ID: 9565623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel heterozygous mutations in TALDO1 gene causing transaldolase deficiency and early infantile liver failure.
    Balasubramaniam S; Wamelink MM; Ngu LH; Talib A; Salomons GS; Jakobs C; Keng WT
    J Pediatr Gastroenterol Nutr; 2011 Jan; 52(1):113-6. PubMed ID: 21119539
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel transketolase inhibitor oroxylin A suppresses the non-oxidative pentose phosphate pathway and hepatocellular carcinoma tumour growth in mice and patient-derived organoids.
    Jia D; Liu C; Zhu Z; Cao Y; Wen W; Hong Z; Liu Y; Liu E; Chen L; Chen C; Gu Y; Jiao B; Chai Y; Wang HY; Fu J; Chen X
    Clin Transl Med; 2022 Nov; 12(11):e1095. PubMed ID: 36314067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of N-acetylcysteine and N-acetylcysteineamide in acetaminophen-induced hepatotoxicity in human hepatoma HepaRG cells.
    Tobwala S; Khayyat A; Fan W; Ercal N
    Exp Biol Med (Maywood); 2015 Feb; 240(2):261-72. PubMed ID: 25245075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypergonadotrophic hypogonadism in a patient with transaldolase deficiency: novel mutation in the pentose phosphate pathway.
    Lafcı NG; Colak FK; Sahin G; Sakar M; Çetinkaya S; Savas-Erdeve S
    Hormones (Athens); 2021 Sep; 20(3):581-585. PubMed ID: 33159679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner.
    Qin Z; Xiang C; Zhong F; Liu Y; Dong Q; Li K; Shi W; Ding C; Qin L; He F
    J Exp Clin Cancer Res; 2019 Apr; 38(1):154. PubMed ID: 30971297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transaldolase deficiency in a two-year-old boy with cirrhosis.
    Wamelink MM; Struys EA; Salomons GS; Fowler D; Jakobs C; Clayton PT
    Mol Genet Metab; 2008 Jun; 94(2):255-8. PubMed ID: 18331807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.